rs149249642

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001378609.3(OTOGL):​c.6283A>G​(p.Ile2095Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000748 in 1,404,176 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0017 ( 1 hom., cov: 26)
Exomes 𝑓: 0.00063 ( 4 hom. )

Consequence

OTOGL
NM_001378609.3 missense

Scores

17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.545

Publications

4 publications found
Variant links:
Genes affected
OTOGL (HGNC:26901): (otogelin like) The protein encoded by this gene belongs to the otogelin family. This gene is expressed in the inner ear of vertebrates with the highest level of expression seen at the embryonic stage and lowest in adult. Knockdown studies in zebrafish suggest that this gene is essential for normal inner ear function. Mutations in this gene are associated with autosomal recessive deafness. [provided by RefSeq, Dec 2012]
OTOGL Gene-Disease associations (from GenCC):
  • autosomal recessive nonsyndromic hearing loss 84B
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008036017).
BP6
Variant 12-80366589-A-G is Benign according to our data. Variant chr12-80366589-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 226967.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00175 (259/148198) while in subpopulation AFR AF = 0.00391 (160/40882). AF 95% confidence interval is 0.00342. There are 1 homozygotes in GnomAd4. There are 117 alleles in the male GnomAd4 subpopulation. Median coverage is 26. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTOGLNM_001378609.3 linkc.6283A>G p.Ile2095Val missense_variant Exon 53 of 59 ENST00000547103.7 NP_001365538.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OTOGLENST00000547103.7 linkc.6283A>G p.Ile2095Val missense_variant Exon 53 of 59 5 NM_001378609.3 ENSP00000447211.2 Q3ZCN5

Frequencies

GnomAD3 genomes
AF:
0.00175
AC:
259
AN:
148174
Hom.:
1
Cov.:
26
show subpopulations
Gnomad AFR
AF:
0.00390
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00272
Gnomad ASJ
AF:
0.000290
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00662
Gnomad NFE
AF:
0.000713
Gnomad OTH
AF:
0.00440
GnomAD2 exomes
AF:
0.000905
AC:
157
AN:
173430
AF XY:
0.000842
show subpopulations
Gnomad AFR exome
AF:
0.00389
Gnomad AMR exome
AF:
0.00161
Gnomad ASJ exome
AF:
0.000734
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000727
Gnomad OTH exome
AF:
0.00253
GnomAD4 exome
AF:
0.000631
AC:
792
AN:
1255978
Hom.:
4
Cov.:
21
AF XY:
0.000623
AC XY:
387
AN XY:
621326
show subpopulations
African (AFR)
AF:
0.00448
AC:
125
AN:
27884
American (AMR)
AF:
0.00218
AC:
68
AN:
31254
Ashkenazi Jewish (ASJ)
AF:
0.000424
AC:
9
AN:
21222
East Asian (EAS)
AF:
0.00
AC:
0
AN:
31318
South Asian (SAS)
AF:
0.0000372
AC:
2
AN:
53724
European-Finnish (FIN)
AF:
0.0000673
AC:
2
AN:
29710
Middle Eastern (MID)
AF:
0.00688
AC:
35
AN:
5084
European-Non Finnish (NFE)
AF:
0.000447
AC:
449
AN:
1004890
Other (OTH)
AF:
0.00200
AC:
102
AN:
50892
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
26
52
78
104
130
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00175
AC:
259
AN:
148198
Hom.:
1
Cov.:
26
AF XY:
0.00162
AC XY:
117
AN XY:
72100
show subpopulations
African (AFR)
AF:
0.00391
AC:
160
AN:
40882
American (AMR)
AF:
0.00265
AC:
39
AN:
14742
Ashkenazi Jewish (ASJ)
AF:
0.000290
AC:
1
AN:
3454
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4994
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4672
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
8920
Middle Eastern (MID)
AF:
0.00719
AC:
2
AN:
278
European-Non Finnish (NFE)
AF:
0.000713
AC:
48
AN:
67288
Other (OTH)
AF:
0.00437
AC:
9
AN:
2058
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.535
Heterozygous variant carriers
0
14
27
41
54
68
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00114
Hom.:
4
Bravo
AF:
0.00212
ESP6500AA
AF:
0.00273
AC:
12
ESP6500EA
AF:
0.000350
AC:
3
ExAC
AF:
0.000923
AC:
110
Asia WGS
AF:
0.00146
AC:
5
AN:
3446

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jan 07, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 12, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Ile2086Val in exon 52 of OTOGL: This variant is not expected to have clinical si gnificance because it has been identified in 4.6% (9/194) of Luhya (Kenyan) chro mosomes from a broad population by the 1000 Genomes Project (http://www.ncbi.nlm .nih.gov/projects/SNP; dbSNP rs149249642). -

OTOGL-related disorder Benign:1
Jul 17, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.62
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
10
DANN
Benign
0.96
Eigen
Benign
-0.98
Eigen_PC
Benign
-0.97
FATHMM_MKL
Benign
0.24
N
LIST_S2
Benign
0.40
T;.;T
M_CAP
Benign
0.0030
T
MetaRNN
Benign
0.0080
T;T;T
MetaSVM
Benign
-1.0
T
PhyloP100
0.55
PrimateAI
Benign
0.29
T
PROVEAN
Benign
-0.67
.;.;N
REVEL
Benign
0.026
Sift
Benign
0.31
.;.;T
Sift4G
Benign
0.33
.;.;T
Vest4
0.13
MVP
0.030
MPC
0.021
ClinPred
0.0013
T
GERP RS
-1.6
gMVP
0.45
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.10
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149249642; hg19: chr12-80760369; API